Immunological serotype interactions and their effect on the epidemiological pattern of dengue

Long-term epidemiological data reveal multi-annual fluctuations in the incidence of dengue fever and dengue haemorrhagic fever, as well as complex cyclical behaviour in the dynamics of the four serotypes of the dengue virus. It has previously been proposed that these patterns are due to the phenomenon of the so-called antibody-dependent enhancement (ADE) among dengue serotypes, whereby viral replication is increased during secondary infection with a heterologous serotype; however, recent studies have implied that this positive reinforcement cannot account for the temporal patterns of dengue and that some form of cross-immunity or external forcing is necessary. Here, we show that ADE alone can produce the observed periodicities and desynchronized oscillations of individual serotypes if its effects are decomposed into its two possible manifestations: enhancement of susceptibility to secondary infections and increased transmissibility from individuals suffering from secondary infections. This decomposition not only lowers the level of enhancement necessary for realistic disease patterns but also reduces the risk of stochastic extinction. Furthermore, our analyses reveal a time-lagged correlation between serotype dynamics and disease incidence rates, which could have important implications for understanding the irregular pattern of dengue epidemics.

[1]  Bob W. Kooi,et al.  Epidemiology of Dengue Fever: A Model with Temporary Cross-Immunity and Possible Secondary Infection Shows Bifurcations and Chaotic Behaviour in Wide Parameter Regions , 2008 .

[2]  Katia Koelle,et al.  Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever , 2008, Proceedings of the National Academy of Sciences.

[3]  A. Nisalak,et al.  A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.

[4]  Ira B Schwartz,et al.  Dynamic effects of antibody-dependent enhancement on the fitness of viruses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Ferguson,et al.  The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Alan L Rothman,et al.  Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. , 2004, The Journal of infectious diseases.

[7]  Donald S Burke,et al.  Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. , 2003, The American journal of tropical medicine and hygiene.

[8]  J. Farrar,et al.  Dengue in Vietnamese infants--results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. , 2008, The Journal of infectious diseases.

[9]  Pejman Rohani,et al.  Ecological and immunological determinants of dengue epidemics. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Edelman Dengue vaccines approach the finish line. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  M. St. Claire,et al.  Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention , 2007, Proceedings of the National Academy of Sciences.

[12]  M. Aye,et al.  Risk factors in dengue shock syndrome. , 1997, The American journal of tropical medicine and hygiene.

[13]  A. Nisalak,et al.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.

[14]  A. Rothman,et al.  Immunopathogenesis of Dengue hemorrhagic fever. , 1999, Virology.

[15]  Ira B Schwartz,et al.  Chaotic desynchronization of multistrain diseases. , 2005, Physical review. E, Statistical, nonlinear, and soft matter physics.

[16]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[17]  N. Karabatsos,et al.  Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.

[18]  E. C. Holmes,et al.  Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok , 2006, Proceedings of the National Academy of Sciences.

[19]  Akira Sasaki,et al.  Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[20]  Mario Recker,et al.  The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types , 2007, Proceedings of the National Academy of Sciences.

[21]  P. Puthavathana,et al.  Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection , 2008, Journal of Virology.

[22]  D. Gubler Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.

[23]  Y. Kawaoka,et al.  Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications , 2003, Reviews in medical virology.

[24]  S. Halstead,et al.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.

[25]  Charles H. Hoke,et al.  SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999 , 2003 .

[26]  C. King,et al.  Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Halstead In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.

[28]  Richard G Jarman,et al.  Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. , 2007, The American journal of tropical medicine and hygiene.

[29]  I. Kurane,et al.  Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002 , 2005, Epidemiology and Infection.